These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3380016)

  • 41. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy.
    Guidoux S; Bozzola M; Larizza D; Schimpff RM
    Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatomedin-C and growth hormone levels in anorexia nervosa in relation to the puberal or post puberal stages.
    Cabranes JA; Almoguera I; Santos JL; Hidalgo I; Borque MM; del Olmo J
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):865-71. PubMed ID: 3241869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly.
    de la Piedra C; Larrañaga J; Castro N; Horcajada C; Rapado A; Herrera Pombo JL; Carbó E
    Calcif Tissue Int; 1988 Jul; 43(1):44-5. PubMed ID: 3145120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity.
    Guidoux S; Garnier PE; Schimpff RM
    Horm Res; 1986; 23(1):31-7. PubMed ID: 3079724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children.
    Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G
    J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma growth hormone and somatomedin-C responses to continuous growth hormone-releasing factor infusion in normal adult men.
    Takano K; Honda N; Shizume K; Hizuka N; Ling NC
    Endocrinol Jpn; 1985 Apr; 32(2):287-93. PubMed ID: 3930225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth in young rats after termination of sodium selenite exposure: studies of growth hormone and somatomedin C.
    Thorlacius-Ussing O; Flyvbjerg A; Orskov H
    Toxicology; 1988 Feb; 48(2):167-76. PubMed ID: 3341044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism.
    Chernausek SD; Underwood LE; Utiger RD; Van Wyk JJ
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):337-44. PubMed ID: 6354519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.
    Ranke MB; Gruhler M; Rosskamp R; Brügmann G; Attanasio A; Blum WF; Bierich JR
    Eur J Pediatr; 1986 Dec; 145(6):485-92. PubMed ID: 2880720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of serum somatomedin-C measurements in dose adjustment and the definition of a biochemical 'cure'.
    Lamberts SW; Uitterlinden P; Schuijff PC; Klijn JG
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):411-20. PubMed ID: 3251673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discrepancies between bioassayable somatomedin activity and somatomedin C levels in acromegalic patients.
    Jasper HG; Artese R; Molocznik I; Bruno O
    Medicina (B Aires); 1986; 46(4):440-4. PubMed ID: 3574106
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R; Prevot C; Brauner R
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of melatonin and hypothyroidism on somatomedin levels of female Syrian hamsters.
    Vriend J; Sheppard MS; Bala RM
    J Pineal Res; 1989; 7(1):85-90. PubMed ID: 2498506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response.
    Stonesifer LD; Jordan RM; Kohler PO
    J Clin Endocrinol Metab; 1981 Nov; 53(5):931-4. PubMed ID: 7197287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.
    Loche S; Cappa M; Borrelli P; Faedda A; Crinò A; Cella SG; Corda R; Müller EE; Pintor C
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):145-53. PubMed ID: 3117449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.